Cargando…
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties
Since in vitro studies and a preliminary clinical report suggested the efficacy of chloroquine for COVID-19-associated pneumonia, there is increasing interest in this old antimalarial drug. In this article, we discuss the pharmacokinetics and safety of chloroquine that should be considered in light...
Autores principales: | Smit, Cornelis, Peeters, Mariska Y. M., van den Anker, John N., Knibbe, Catherijne A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165255/ https://www.ncbi.nlm.nih.gov/pubmed/32306288 http://dx.doi.org/10.1007/s40262-020-00891-1 |
Ejemplares similares
-
Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications
por: Helfer, Hélène, et al.
Publicado: (2019) -
Pharmacokinetics and Generic Drug Switching: A Regulator’s View
por: Glerum, Pieter J., et al.
Publicado: (2020) -
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
por: Facente, Shelley N., et al.
Publicado: (2021) -
Inappropriate Use of Antimicrobials for Lower Respiratory Tract Infections in Elderly Patients: Patient- and Community-Related Implications and Possible Interventions
por: van Heijl, Inger, et al.
Publicado: (2018) -
Combining Isotopic Tracer Techniques to Increase Efficiency of Clinical Pharmacokinetic Trials in Oncology
por: Roosendaal, Jeroen, et al.
Publicado: (2020)